Justin B. Echouffo-Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo-Jack
{"title":"前驱糖尿病的诊断和治疗:综述","authors":"Justin B. Echouffo-Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo-Jack","doi":"10.1097/ogx.0000000000001177","DOIUrl":null,"url":null,"abstract":"(Abstracted from JAMA 2023;329(14):1206–1216) Prediabetes is a highly prevalent intermediate stage of glucose dysregulation that may precede type 2 diabetes. In the United States, approximately 10% of those with prediabetes will develop diabetes each year, and the prevalence of prediabetes is steadily increasing.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis and Management of Prediabetes: A Review\",\"authors\":\"Justin B. Echouffo-Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo-Jack\",\"doi\":\"10.1097/ogx.0000000000001177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"(Abstracted from JAMA 2023;329(14):1206–1216) Prediabetes is a highly prevalent intermediate stage of glucose dysregulation that may precede type 2 diabetes. In the United States, approximately 10% of those with prediabetes will develop diabetes each year, and the prevalence of prediabetes is steadily increasing.\",\"PeriodicalId\":19409,\"journal\":{\"name\":\"Obstetrical & Gynecological Survey\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obstetrical & Gynecological Survey\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ogx.0000000000001177\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrical & Gynecological Survey","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ogx.0000000000001177","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
(Abstracted from JAMA 2023;329(14):1206–1216) Prediabetes is a highly prevalent intermediate stage of glucose dysregulation that may precede type 2 diabetes. In the United States, approximately 10% of those with prediabetes will develop diabetes each year, and the prevalence of prediabetes is steadily increasing.
期刊介绍：
Each monthly issue of Obstetrical & Gynecological Survey presents summaries of the most timely and clinically relevant research being published worldwide. These concise, easy-to-read summaries provide expert insight into how to apply the latest research to patient care. The accompanying editorial commentary puts the studies into perspective and supplies authoritative guidance. The result is a valuable, time-saving resource for busy clinicians.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
